Skip to the page

Data / Drug companies / Isotretinoin

Isotretinoin: 16 companies and 97 products in the FDA NDC directory

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Isotretinoin is listed in the FDA National Drug Code Directory by 16 companies, with 97 products in commercial distribution. 81 of the products (83.5%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are capsule; capsule, liquid filled; capsule, gelatin coated, and the newest product started marketing on September 10, 2026.

The request: Get every company that lists isotretinoin in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
16
Products
97
Generic (ANDA) products
81 (83.5%)
Application numbers
16
Routes
Oral
Brand names
Zenatane, Absorica, Absorica LD, Claravis, Accutane, Amnesteem
openFDA record search
api.fda.gov

Companies that list isotretinoin

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Amneal Pharmaceuticals NY LLC10capsule; capsule, liquid filledGeneric drugs (ANDA)October 10, 2025
Sun Pharmaceutical Industries, Inc.10capsuleNew drug applications (NDA)November 20, 2019
Zydus Lifesciences Limited10capsuleGeneric drugs (ANDA)June 9, 2025
Zydus Pharmaceuticals USA Inc.10capsuleGeneric drugs (ANDA)June 9, 2025
Mayne Pharma8capsule, liquid filledGeneric drugs (ANDA)September 21, 2021
Actavis Pharma, Inc.6capsuleGeneric drugs (ANDA)April 29, 2021
Aurobindo Pharma Limited6capsuleGeneric drugs (ANDA)January 29, 2024
Sun Pharmaceutical Industries, Inc.6capsuleAuthorized generics (NDA)December 29, 2020
BluePoint Laboratories4capsule, gelatin coatedGeneric drugs (ANDA)December 30, 2025
Dr. Reddy's Laboratories Limited4capsule, gelatin coatedGeneric drugs (ANDA)March 9, 2015
JG Pharma Inc.4capsule, gelatin coatedGeneric drugs (ANDA)August 1, 2022
Mylan Pharmaceuticals Inc.4capsuleGeneric drugs (ANDA)April 10, 2025
Teva Pharmaceuticals USA, Inc.4capsule, liquid filledGeneric drugs (ANDA)May 18, 2006
Upsher-Smith Laboratories, LLC4capsule, liquid filledGeneric drugs (ANDA)September 21, 2021
Upsher-Smith Laboratories, LLC4capsule, liquid filledGeneric drugs (ANDA)August 26, 2015
Aurobindo Pharma Limited3capsuleGeneric drugs (ANDA)September 10, 2026

Dosage forms

Dosage formProductsShare
Capsule6162.9%
Capsule, liquid filled2424.7%
Capsule, gelatin coated1212.4%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)8183.5%
New drug applications (NDA)1010.3%
Authorized generics (NDA)66.2%

Pharmacologic classes

ClassProducts
Retinoid97

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.